Bicocca Open Archive

Logo unimib boa
ALIBERTI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.967
AS - Asia 5.459
EU - Europa 4.903
SA - Sud America 892
Continente sconosciuto - Info sul continente non disponibili 234
AF - Africa 135
OC - Oceania 19
Totale 25.609
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.270
SG - Singapore 1.948
CN - Cina 1.292
IT - Italia 874
HK - Hong Kong 798
DE - Germania 748
RU - Federazione Russa 734
BR - Brasile 687
VN - Vietnam 614
SE - Svezia 593
CA - Canada 565
UA - Ucraina 542
IE - Irlanda 471
GB - Regno Unito 244
FR - Francia 223
IN - India 154
FI - Finlandia 152
BD - Bangladesh 137
AT - Austria 112
AR - Argentina 80
KR - Corea 63
ID - Indonesia 61
TR - Turchia 58
NL - Olanda 48
IQ - Iraq 47
ZA - Sudafrica 46
PK - Pakistan 41
MX - Messico 39
SA - Arabia Saudita 38
JP - Giappone 35
CO - Colombia 30
CZ - Repubblica Ceca 28
EC - Ecuador 28
ES - Italia 26
PH - Filippine 26
PL - Polonia 25
UZ - Uzbekistan 24
DK - Danimarca 21
VE - Venezuela 20
EG - Egitto 17
CR - Costa Rica 16
HN - Honduras 16
JM - Giamaica 16
CL - Cile 14
BE - Belgio 13
TT - Trinidad e Tobago 13
MY - Malesia 12
NP - Nepal 12
AE - Emirati Arabi Uniti 11
PE - Perù 11
AU - Australia 10
KE - Kenya 10
PY - Paraguay 10
TN - Tunisia 10
JO - Giordania 9
LB - Libano 9
NZ - Nuova Zelanda 9
TH - Thailandia 9
AL - Albania 8
DZ - Algeria 8
GT - Guatemala 8
KZ - Kazakistan 8
MA - Marocco 8
PS - Palestinian Territory 8
UY - Uruguay 8
AZ - Azerbaigian 7
ET - Etiopia 7
SV - El Salvador 7
IL - Israele 6
TW - Taiwan 6
BG - Bulgaria 5
CH - Svizzera 5
IR - Iran 5
PT - Portogallo 5
RO - Romania 5
GR - Grecia 4
MD - Moldavia 4
OM - Oman 4
SN - Senegal 4
BO - Bolivia 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
KH - Cambogia 3
KW - Kuwait 3
LT - Lituania 3
NG - Nigeria 3
NI - Nicaragua 3
PA - Panama 3
SC - Seychelles 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
BW - Botswana 2
CG - Congo 2
CI - Costa d'Avorio 2
EE - Estonia 2
EU - Europa 2
GP - Guadalupe 2
LY - Libia 2
Totale 25.352
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.381
Ashburn 1.244
Woodbridge 1.165
Singapore 1.073
Fairfield 866
Hong Kong 792
Houston 783
San Jose 611
Jacksonville 567
Dublin 460
Chandler 456
Council Bluffs 390
Wilmington 370
Seattle 364
Dearborn 346
Toronto 339
Cambridge 302
Frankfurt am Main 270
Milan 270
New York 256
Beijing 241
Princeton 227
Ho Chi Minh City 189
Chicago 188
Santa Clara 167
Los Angeles 150
The Dalles 145
Hanoi 125
Nanjing 119
Hangzhou 110
Altamura 108
Shanghai 100
Vienna 98
Lachine 97
Lauterbourg 97
Lawrence 95
Dallas 89
Moscow 84
São Paulo 64
Buffalo 63
Rome 63
Seoul 59
Hefei 57
Nanchang 46
Helsinki 45
San Diego 41
Columbus 39
Ottawa 34
Shenyang 34
Brooklyn 33
Dong Ket 30
Hebei 29
Phoenix 29
Jakarta 28
Jiaxing 28
London 28
Orem 28
Covington 27
Dhaka 27
Munich 27
Rio de Janeiro 27
Guangzhou 26
Salt Lake City 25
Haiphong 24
Atlanta 23
Brno 23
Jinan 23
Montreal 23
Norwalk 23
Andover 22
Tokyo 22
Da Nang 21
Tianjin 21
Boardman 20
Changsha 20
Falls Church 20
Tashkent 20
Warsaw 19
Amsterdam 18
Jeddah 17
Miami 17
Ningbo 17
North Bergen 17
Denver 16
Mountain View 16
Newark 15
Tampa 15
Baghdad 14
Chennai 14
Fremont 14
Huizen 14
Naples 14
Belo Horizonte 13
Boston 13
Riyadh 13
San Francisco 13
Turin 13
Johannesburg 12
Las Vegas 12
New Delhi 12
Totale 16.314
Salva come PNG Salva come JPEG
Nome #
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 433
Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia 407
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia 377
Clinical phenotypes in adult patients with bronchiectasis 362
Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia 344
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 343
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases 332
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 332
Multidimensional severity assessment in bronchiectasis: An analysis of seven European cohorts 322
Dyspnea in crackling lungs 321
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: A multinational point prevalence study of hospitalised patients 316
Impact of traffic-related air pollution on pulmonary oxidative stress 314
Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity 310
A 61-year-old female with chronic cough and purulent sputum 309
Influenza A/H1N1 severe pneumonia: Novel morphocytological findings in bronchoalveolar lavage 301
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia 299
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study 297
Phenotyping in Bronchiectasis: Are we moving towards a personalized medicine? 295
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study 286
The management of community-acquired pneumonia in the elderly 283
Nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae in an Italian university hospital: a molecular epidemiological study 279
Individualizing duration of antibiotic therapy in community-acquired pneumonia 274
Prulifloxacin: A brief review of its potential in the treatment of acute exacerbation of chronic bronchitis 271
Geriatric multidimensional assessment for elderly patients with acute respiratory diseases 269
Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis 266
Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study 264
Diaphragm ultrasonography in the management of patients with amyotrophic lateral sclerosis 263
Mortality in acute cardiogenic pulmonary edema treated with continuous positive airway pressure 262
A 13-year-old female with shortness of breath and pleuritic chest pain 261
Hospital admission decision for patients with community-acquired pneumonia 257
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study 257
Mixed community-acquired lower respiratory tract infections 253
The Clinical and Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease: A Cohort of Hospitalized Patients 248
Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia 248
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia 248
Early administration of the first antimicrobials should be considered a marker of optimal care of patients with community-acquired pneumonia rather than a predictor of outcomes 245
Acute myocardial infarction versus other cardiovascular events in communityacquired pneumonia 244
Azithromycin and lower respiratory tract infections 243
Non-invasive continuous positive airway pressure in monolateral lung transplant patient with pneumonia and IPF 243
Microbiological Diagnosis and Antibiotic Therapy in Patients with Community-Acquired Pneumonia and Acute COPD Exacerbation in Daily Clinical Practice: Comparison to Current Guidelines 243
Strategic targets of essential host-pathogen interactions 238
Are multi-drug resistant (MDR) pathogens related to higher mortality in pneumonia? 237
100 years of respiratory medicine: pneumonia 236
Chlamydia pneumoniae and acute aortic syndrome: A call for a multi-institutional study 236
Do prognostic factors help physicians in predicting legionellosis' respiratory complications? 236
Chlamydophila pneumoniae 236
The bronchiectasis severity index. An international derivation and validation study 229
The role of lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia 228
Contrasting Inflammatory Responses in Severe and Non-severe Community-acquired Pneumonia 228
Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia 227
Pneumonia: how important are local epidemiology and smoking habits? 227
Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy 226
Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia 224
Acidemia does not affect outcomes of patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure 223
Usefulness of simplified acute physiology score II in predicting mortality in patients admitted to an emergency medicine ward 223
Stratifying Risk Factors for Multidrug-Resistant Pathogens in Hospitalized Patients Coming From the Community With Pneumonia 223
Criteria for clinical stability in hospitalised patients with community-acquired pneumonia 222
Early application of non-invasive continuous positive airway pressure in acute respiratory distress syndrome due to a drug overdose: a case report 217
Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia 217
Non-invasive-ventilation in H1N1 acute respiratory failure in emergency department: A case series 217
Noninvasive ventilation or continuous positive airway pressure in pulmonary edema patients with respiratory acidosis? Look at the bicarbonates 216
Compliance with anti-H1N1 vaccine among healthcare workers and general population 214
Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis 214
Should health care systems and health care providers implement a new pathway for hospitalized patients with community-acquired pneumonia? 213
Clinical and economical impact of exacerbations of chronic obstructive pulmonary disease (COPD): a two year study 210
Acute myocardial infarction in hospitalized patients with community-acquired pneumonia 208
COPD and bronchiectasis: Phenotype, endotype or co-morbidity? 207
Validation of the 3CPO-score in a prospective cohort of Acute Cardiogenic Pulmonary Edema (ACPE) patients 207
The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study 207
Predicting Mycobacterium tuberculosis in patients with community-acquired pneumonia 204
Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia 201
Low CURB-65 is of limited value in deciding discharge of patients with community-acquired pneumonia 201
The management of patients with community-acquired pneumonia beyond antibiotic therapy 201
The pneumonia severity index and the CRB-65 in cancer patients with community-acquired pneumonia 200
Pneumonia in the community caused by multidrug-resistant organisms: keep working on probabilistic scores 200
Acute exacerbation of COPD: application of evidence-based guidelines 199
Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection 195
Chlamydia pneumoniae and Mycoplasma pneumoniae 195
“Normotension” on admission to the emergency department affects outcome of patients with acute cardiogenic pulmonary edema (ACPE) 195
Management of nontuberculous mycobacterial infection in the elderly 195
Highlights on the appropriate use of fluoroquinolones in respiratory tract infections 194
Clinical Stability versus Clinical Failure in Patients with Community-Acquired Pneumonia 194
The role of biomarkers in low respiratory tract infections 193
Clinical applications of azithromycin microspheres in respiratory tract infections 192
Antibiotics as immunomodulant agents in COPD 192
Impact of exacerbations in the natural course of COPD 191
Telithromycin in lower respiratory tract infections 190
Cardiac diseases complicating community-acquired pneumonia 189
Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia 186
Is it time for a "pneumo-geriatrician" for frail old patients with respiratory diseases? 186
Healthcare-associated pneumonia: where do we go next? 185
Pneumococcal Vaccine and Patients with Pulmonary Diseases 183
Acute effects of positive end-expiratory pressure on left ventricle diastolic function in healthy subjects 181
The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia 178
Lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia. A prospective multicentre diagnostic accuracy study 177
Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective 177
Early outcomes in CAP: Clinical stability, clinical failure and nonresolving pneumonia 177
Where are the acutely ill best cared for and who should look after them? 173
Helmet continuous positive airway pressure vs oxygen therapy to improve oxygenation in community-acquired pneumonia: a randomized, controlled trial 171
Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia 169
Totale 24.031
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.700
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022802 0 0 0 90 52 103 55 61 64 86 93 198
2022/20231.833 250 532 224 133 92 315 9 90 133 4 25 26
2023/20241.249 35 32 47 31 172 335 254 57 153 15 10 108
2024/20252.827 205 348 76 141 275 60 82 79 313 474 326 448
2025/20267.557 694 427 538 874 777 401 999 442 626 685 503 591
2026/20272.203 181 320 763 939 0 0 0 0 0 0 0 0
Totale 25.609